1. Web alert

   News Pages: 109 - 111

2. Literature alert

   Abstract Pages: 112 - 116

3. Angiotensin receptors and the kidney

   • Robert M. Carey

   Invited Commentary Pages: 117 - 117

4. The effects of weight loss and other nonpharmacologic interventions on blood pressure

   • Dalila B. Corry
   • Michael L. Tuck

   Clinical Trials Review Pages: 118 - 118

5. Obesity, hypertension, and sympathetic nervous system activity

   • Dalila B. Corry
   • Michael L. Tuck

   OriginalPaper Pages: 119 - 126

6. Obesity and cardiovascular hemodynamic function

   • Rainer Koch
   • Arya M. Sharma

   OriginalPaper Pages: 127 - 130

7. Lipid disorders in obesity

   • Susanne B. Nicholas

   OriginalPaper Pages: 131 - 136

8. Pathology of renal complications in obesity

   • Arthur H. Cohen

   OriginalPaper Pages: 137 - 139

9. Obesity, hypertension, and vascular disease

   • Kurt M. R. Sowers
   • James R. Sowers

   OriginalPaper Pages: 140 - 144

10. Obesity, blood pressure, and renal sodium handling

    • Myron H. Weinberger

    OriginalPaper Pages: 145 - 148

11. The salt-blood pressure controversy: What are the issues?

    • Myron H. Weinberger

    Clinical Trials Review Pages: 149 - 150

12. Novel actions of angiotensin II via its renal type-2 (AT₂) receptor

    • Robert M. Carey
    • Zhi-Qin Wang
    • Helmy M. Siragy

    OriginalPaper Pages: 151 - 157

13. The epithelial sodium channel in hypertension

    • David G. Warnock

    OriginalPaper Pages: 158 - 163

14. The kidney as a target of hypertension

    • Susanne Ljungman

    OriginalPaper Pages: 164 - 169

15. Antihypertensive drugs and diabetic nephropathy

    • Philip S. Mehler
    • Robert W. Schrier

    OriginalPaper Pages: 170 - 177

16. Role of nitric oxide in the control of renal function and salt sensitivity

    • Ai-Ping Zou
    • Allen W. Cowley Jr

    OriginalPaper Pages: 178 - 186

17. New insights into the renin-angiotensin system and hypertensive renal disease

    • Agnes B. Fogo

    OriginalPaper Pages: 187 - 194